ZA972829B - Novel pyrimido [1,2-a]indoles. - Google Patents

Novel pyrimido [1,2-a]indoles.

Info

Publication number
ZA972829B
ZA972829B ZA9702829A ZA972829A ZA972829B ZA 972829 B ZA972829 B ZA 972829B ZA 9702829 A ZA9702829 A ZA 9702829A ZA 972829 A ZA972829 A ZA 972829A ZA 972829 B ZA972829 B ZA 972829B
Authority
ZA
South Africa
Prior art keywords
indoles
novel pyrimido
pyrimido
novel
Prior art date
Application number
ZA9702829A
Other languages
English (en)
Inventor
Muller Ulrich
Eckenberg Peter
Grutzmann Rudi
Bischoff Hilmar
Denzer Dirk
Wohlfeil Stefan
Lohmer Stefan
Nielsch Ulrich
Kolkhof Peter
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA972829B publication Critical patent/ZA972829B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA9702829A 1996-04-04 1997-04-03 Novel pyrimido [1,2-a]indoles. ZA972829B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19613550A DE19613550A1 (de) 1996-04-04 1996-04-04 Neue Pyrimido[1,2-a]indole

Publications (1)

Publication Number Publication Date
ZA972829B true ZA972829B (en) 1997-10-31

Family

ID=7790502

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9702829A ZA972829B (en) 1996-04-04 1997-04-03 Novel pyrimido [1,2-a]indoles.

Country Status (33)

Country Link
US (1) US6114341A (pt)
EP (1) EP0799828A3 (pt)
JP (1) JPH1059972A (pt)
KR (1) KR970070008A (pt)
CN (2) CN1067393C (pt)
AR (1) AR006497A1 (pt)
AU (1) AU725786B2 (pt)
BG (1) BG62934B1 (pt)
BR (1) BR9701675A (pt)
CA (1) CA2201434A1 (pt)
CO (1) CO4520306A1 (pt)
CZ (1) CZ102297A3 (pt)
DE (1) DE19613550A1 (pt)
DZ (1) DZ2201A1 (pt)
EE (1) EE9700078A (pt)
HN (1) HN1997000045A (pt)
HR (1) HRP970154A2 (pt)
HU (1) HUP9700708A3 (pt)
ID (1) ID16520A (pt)
IL (3) IL120590A (pt)
MA (1) MA24131A1 (pt)
MY (1) MY126362A (pt)
NO (1) NO309092B1 (pt)
NZ (1) NZ314497A (pt)
PE (1) PE42398A1 (pt)
PL (1) PL319249A1 (pt)
SG (1) SG63698A1 (pt)
SK (1) SK42797A3 (pt)
SV (1) SV1997000025A (pt)
TN (1) TNSN97061A1 (pt)
TR (1) TR199700261A2 (pt)
YU (1) YU12397A (pt)
ZA (1) ZA972829B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19826469A1 (de) * 1998-06-13 2000-05-25 Bayer Ag Verfahren zur Herstellung von 2,4-Dimethylcarbolin und 2,4-Dimethylpyrimido[1,2-a]indol
WO2001074817A1 (fr) * 2000-03-30 2001-10-11 Yamanouchi Pharmaceutical Co., Ltd. Derives d'hydrazide
DE10030375A1 (de) * 2000-06-21 2002-01-03 Bayer Ag Verwendung von MTP-Inhibitoren zur Senkung von ppTRL
JP4254093B2 (ja) * 2001-10-17 2009-04-15 宇部興産株式会社 5−ハロゲノインドールの製法
DE10349175A1 (de) * 2003-10-22 2005-05-19 Bayer Healthcare Ag Mittel zur Gewichtsreduktion
SI1725234T1 (sl) 2004-03-05 2013-04-30 The Trustees Of The University Of Pennsylvania Postopki zdravljenja nepravilnosti ali bolezni povezanih s hiperlipidemijo in hiperholesterolemijo z minimiziranjem stranskih uäśinkov
EP1737460A2 (en) * 2004-04-09 2007-01-03 Janssen Pharmaceutica N.V. Intermittent dosing regimen for the treatment of overweight with mtp-inhibitors
CA2946470C (en) 2005-05-12 2019-02-19 C.R. Bard Inc. Removable embolus blood clot filter
CA2609783A1 (en) * 2005-05-27 2006-12-07 Pfizer Products Inc. Combination of a cannabinoid-1- receptor-antagonist and a microsomal triglyceride transfer protein inhibitor for treating obesity or mainataining weight loss
WO2007021340A1 (en) 2005-08-09 2007-02-22 C.R. Bard Inc Embolus blood clot filter and delivery system
EP1951224A2 (en) * 2005-10-18 2008-08-06 Aegerion Pharmaceuticals Methods for treating disorders associated with hyperlipidemia in a mammal
US10188496B2 (en) 2006-05-02 2019-01-29 C. R. Bard, Inc. Vena cava filter formed from a sheet
US20080161279A1 (en) * 2006-12-21 2008-07-03 Wisler Gerald L Methods of Treating Obesity

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA718536B (en) * 1971-01-11 1972-09-27 Wyeth John & Brother Ltd Heterocyclic compounds
DE2200584A1 (de) * 1971-01-11 1972-07-27 Wyeth John & Brother Ltd Heterocyclische Verbindungen,Verfahren zu ihrer Herstellung und ihre Verwendung in pharmazeutischen Zubereitungen
GB8614246D0 (en) * 1986-06-11 1986-07-16 Wyeth John & Brother Ltd Substituted pyrimidoindoles
DE4112533A1 (de) * 1991-04-17 1992-10-22 Bayer Ag Verfahren zur herstellung von enantiomerenreinen substituierten (chinolin-2-yl-methoxy)phenyl-essigsaeuren
DE4200954A1 (de) * 1991-04-26 1992-10-29 Bayer Ag Heterocyclisch substituierte phenylessigsaeurederivate
DE4208052A1 (de) * 1992-03-13 1993-09-16 Bayer Ag Imidazolyl substituierte phenylessigsaeureamide
DE4208051A1 (de) * 1992-03-13 1993-09-16 Bayer Ag Substituierte phenylessigsaeureamide
US5576342A (en) * 1992-03-13 1996-11-19 Bayer Aktiengesellschaft Phenylglycinamides of heterocyclically substitued phenylacetic acid derivatives
DE4309968A1 (de) * 1993-03-26 1994-09-29 Bayer Ag Phenylglycinamide von heterocyclisch substituierten Phenylessigsäurederivaten
EP0667867A1 (en) * 1992-11-05 1995-08-23 Smithkline Beecham Plc Piperidine derivatives as 5-ht4 receptor antagonists
DE4302956A1 (de) * 1993-02-03 1994-08-04 Bayer Ag Substituierte Imidazo(4,5-b)pyridine und Benzimidazole

Also Published As

Publication number Publication date
NO971512D0 (no) 1997-04-03
HRP970154A2 (en) 1998-04-30
HUP9700708A3 (en) 2000-01-28
NO971512L (no) 1997-10-06
IL120590A0 (en) 1997-08-14
EE9700078A (et) 1997-10-15
BG62934B1 (bg) 2000-11-30
PL319249A1 (en) 1997-10-13
MX9702445A (es) 1997-10-31
CZ102297A3 (en) 1997-10-15
EP0799828A3 (de) 1998-04-08
CN1067393C (zh) 2001-06-20
YU12397A (en) 1999-11-22
AR006497A1 (es) 1999-08-25
IL131645A (en) 2000-12-06
CO4520306A1 (es) 1997-10-15
US6114341A (en) 2000-09-05
HUP9700708A2 (hu) 1998-10-28
SV1997000025A (es) 1997-10-23
ID16520A (id) 1997-10-09
EP0799828A2 (de) 1997-10-08
HU9700708D0 (en) 1997-05-28
KR970070008A (ko) 1997-11-07
TNSN97061A1 (fr) 2005-03-15
CA2201434A1 (en) 1997-10-04
TR199700261A2 (xx) 1997-10-21
NZ314497A (en) 1999-10-28
CN1312246A (zh) 2001-09-12
JPH1059972A (ja) 1998-03-03
IL131645A0 (en) 2001-01-28
MY126362A (en) 2006-09-29
AU725786B2 (en) 2000-10-19
AU1660397A (en) 1997-10-09
PE42398A1 (es) 1998-10-12
DE19613550A1 (de) 1997-10-09
NO309092B1 (no) 2000-12-11
DZ2201A1 (fr) 2002-12-03
SG63698A1 (en) 1999-03-30
BR9701675A (pt) 1998-11-03
BG101379A (en) 1997-11-28
IL120590A (en) 2000-02-17
CN1176965A (zh) 1998-03-25
MA24131A1 (fr) 1997-10-01
SK42797A3 (en) 1997-11-05
HN1997000045A (es) 1997-06-26

Similar Documents

Publication Publication Date Title
AP9701077A0 (en) Substituted 6,5-hetero bicyclic derivatives
AP9701076A0 (en) Substituted 6,6-hetero bicyclic derivatives
ZA979593B (en) Naphthyridine derivatives.
AU5592298A (en) Multi-purpose dolly-truck
HK1021734A1 (en) Substituted pyrido 6,6-bicyclic derivatives
ZA97521B (en) 19-Nor-pregnene derivatives.
GR3036523T3 (en) 8-substituted-1,3,8-triazaspiro[4.5]decan-4-on derivatives
HRP980398B1 (en) 5H-THIAZOLO /3,2-a/ PYRIMIDINE DERIVATIVES
MXPA00007634A (es) Nuevos compuestos de triazol (4,5-d) pirimidina.
HK1018457A1 (en) Alkylaminobenzothiazole and-benzoxazole derivatives.
ZA972829B (en) Novel pyrimido [1,2-a]indoles.
SG79259A1 (en) Diaza-spiro[3,5]nonane deravatives
ZA9610781B (en) 2,7-substituted octahydro-pyrrolo(1,2-A)pyrazine derivatives.
GB2311779B (en) 2,3 benzodiazepine derivatives
AU5172296A (en) Pyrimido{4,5-b}indoles
HUP0003692A3 (en) Pyrimido[4,5-b]indolyl-alkanecarboxamide derivatives
ZA974538B (en) Novel pyrrole derivatives.
GB2316072B (en) Pyrrolo[3,2-c]quinoline derivatives
ZA972984B (en) Spiro[cyclopent[b]indole-piperidines.
ZA975626B (en) Antineurodegenerative ergoline derivatives.
ZA971167B (en) Heterocyclyl-ergoline derivatives.
CY2322B1 (en) Benzoaeguequinoline derivatives.
AU7073296A (en) 5,6,7,8-tetrahydropyrido{2,3-d}pyrimidines
HU9700545D0 (en) (2,3-dihydro-5-benzofuranyl)-acetonitril
AU6344396A (en) 5,6,7,8-tetrahydropyrimido{4,5-b}azepine derivatives